These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 7454280)

  • 21. Development of a lipoprotein profile using capillary electrophoresis and mass spectrometry.
    Macfarlane RD; Bondarenko PV; Cockrill SL; Cruzado ID; Koss W; McNeal CJ; Spiekerman AM; Watkins LK
    Electrophoresis; 1997 Sep; 18(10):1796-806. PubMed ID: 9372272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reference serum protein and lipoprotein fractions of ostriches (Struthio camelus) in Turkey.
    Polat U; Cetin M; Turkyilmaz O; Yalcin A
    Onderstepoort J Vet Res; 2004 Mar; 71(1):77-9. PubMed ID: 15185578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The decrease in gamma-tocopherol in plasma and lipoprotein fractions levels off within two days of vitamin E supplementation.
    Sundl I; Resch U; Bergmann AR; Roob JM; Winklhofer-Roob BM
    Ann N Y Acad Sci; 2004 Dec; 1031():378-80. PubMed ID: 15753174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevention of coronary disease: role of high density lipoproteins (HDL)].
    Pouliot M
    Union Med Can; 1983 Jan; 112(1):28-30. PubMed ID: 6836774
    [No Abstract]   [Full Text] [Related]  

  • 25. In vivo studies of VLDL metabolism and LDL heterogeneity.
    Demant T; Packard C
    Eur Heart J; 1998 Jul; 19 Suppl H():H7-10. PubMed ID: 9717058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
    Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
    Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholesterol: good and bad.
    Horwitz DL
    Compr Ther; 1980 Jan; 6(1):3-4. PubMed ID: 7357841
    [No Abstract]   [Full Text] [Related]  

  • 29. Fish eye disease.
    Philipson BT
    Birth Defects Orig Artic Ser; 1982; 18(6):441-8. PubMed ID: 6756500
    [No Abstract]   [Full Text] [Related]  

  • 30. [Role o glucocorticoids in etiology of hyperlipoproteinemia].
    Titov VN; Tvorogova MG; Masenko VP; Chvileva OP; Krylova EA
    Ter Arkh; 1981; 53(12):40-5. PubMed ID: 7336341
    [No Abstract]   [Full Text] [Related]  

  • 31. HDL and coronary heart disease.
    Lancet; 1980 Nov; 2(8204):1139-40. PubMed ID: 6107751
    [No Abstract]   [Full Text] [Related]  

  • 32. [Sports and organ function].
    Howald H
    Schweiz Z Sportmed; 1986 Mar; 34(1):17-9. PubMed ID: 3823832
    [No Abstract]   [Full Text] [Related]  

  • 33. [Beta- and alpha 1-lipoprotein levels after application of sodium sulfate and sodium chloride mineral waters in children with duodenal ulcer and gastroduodenitis].
    Guliaev GK; El'nikova TN; Shkoliar AV; Lagkuti NS; Isaeva LA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1985; (4):29-31. PubMed ID: 4060656
    [No Abstract]   [Full Text] [Related]  

  • 34. Nutrition and therapeutics.
    Laker MF
    Curr Opin Lipidol; 1997 Feb; 8(1):U1-3. PubMed ID: 9127714
    [No Abstract]   [Full Text] [Related]  

  • 35. [Importance of the determination of Lp(a) in the prevention of coronary risk].
    Masdeu S; Rosselló J; Chacón P; Campins M
    Med Clin (Barc); 1987 Nov; 89(17):755. PubMed ID: 3695718
    [No Abstract]   [Full Text] [Related]  

  • 36. Alcohol and coronary-artery disease.
    Barboriak JJ
    Lancet; 1977 Jun; 1(8023):1212-3. PubMed ID: 68316
    [No Abstract]   [Full Text] [Related]  

  • 37. High density lipoprotein in prediction of coronary heart disease.
    Craig IH; Need AG; Pain RW; Phillips PJ; Sobecki S
    Med J Aust; 1980 Apr; 1(8):393. PubMed ID: 7393090
    [No Abstract]   [Full Text] [Related]  

  • 38. In search of the ideal measure of high-density lipoprotein.
    Reed RG
    Clin Chem; 1997 Oct; 43(10):1809-10. PubMed ID: 9341996
    [No Abstract]   [Full Text] [Related]  

  • 39. HDL particle measurements: impact for diagnosis and therapy.
    Bard JM; Fruchart JC
    Clin Biochem; 1993 Apr; 26(2):65-8. PubMed ID: 8485858
    [No Abstract]   [Full Text] [Related]  

  • 40. Symptomatic coronary artery disease in a marathon runner.
    JAMA; 1983 Feb; 249(7):881-2. PubMed ID: 6823035
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.